Skip to content

Drug interactions

Anti-thymocyte + Influenza virus vaccine quadrivalent recombinant

Severity: Moderate

Anti-thymocyte and Influenza virus vaccine quadrivalent recombinant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Anti-thymocyte globulin depletes T cells and can weaken the antibody response to inactivated or recombinant influenza vaccines. The vaccine is not harmful, but protection may be inadequate.

What this interaction means in plain words

Anti-thymocyte and Influenza virus vaccine quadrivalent recombinant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

T-cell depletion reduces immunogenicity of the vaccine.

What to do

Vaccinate when clinically indicated and do not withhold annual influenza immunization, though ideally before therapy. Consider household vaccination and early antiviral treatment if exposed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anti-thymocyte and Influenza virus vaccine quadrivalent recombinant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Anti-thymocyte with Influenza virus vaccine quadrivalent recombinant?

MediHelp rates the interaction as moderate. Anti-thymocyte and Influenza virus vaccine quadrivalent recombinant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Anti-thymocyte globulin depletes T cells and can weaken the antibody response to inactivated or recombinant influenza vaccines. The vaccine is not harmful, but protection may be inadequate.

How serious is the interaction between Anti-thymocyte and Influenza virus vaccine quadrivalent recombinant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate when clinically indicated and do not withhold annual influenza immunization, though ideally before therapy. Consider household vaccination and early antiviral treatment if exposed.

What other medicines interact with Anti-thymocyte?

MediHelp also lists interactions of Anti-thymocyte with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Anti-thymocyte page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in